HIND
Price:
$5.09
Market Cap:
$134.21M
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.
Industry
Biotechnology
IPO Date
2016-10-06
Stock Exchange
NASDAQ
Ticker
HIND
According to Vyome Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -24.24. This represents a change of 5.79% compared to the average of -0.41 of the last 4 quarters.
The mean historical PE Ratio of Vyome Holdings, Inc. over the last ten years is -5.91. The current -24.24 PE Ratio has changed 40.93% with respect to the historical average. Over the past ten years (40 quarters), HIND's PE Ratio was at its highest in in the March 2025 quarter at 0.47. The PE Ratio was at its lowest in in the December 2015 quarter at -177072883.36.
Average
-5.91
Median
-1.11
Minimum
-39.30
Maximum
0
Discovering the peaks and valleys of Vyome Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 147.00%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -39.30
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.29 | 147.00% |
| 2023 | -0.52 | 110.95% |
| 2022 | -0.25 | -78.19% |
| 2021 | -1.14 | 4.79% |
| 2020 | -1.08 | 124.70% |
| 2019 | -0.48 | -75.18% |
| 2018 | -1.94 | -85.14% |
| 2017 | -13.07 | -Infinity% |
| 2016 | 0 | -100.00% |
| 2015 | -39.30 | 2.47% |
The current PE Ratio of Vyome Holdings, Inc. (HIND) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.69
5-year avg
-0.86
10-year avg
-5.91
Vyome Holdings, Inc.’s PE Ratio is less than C4 Therapeutics, Inc. (-1.58), less than Armata Pharmaceuticals, Inc. (-4.59), less than Sangamo Therapeutics, Inc. (-2.15), less than Tonix Pharmaceuticals Holding Corp. (-2.69), less than Compugen Ltd. (-7.78), less than Nuvectis Pharma, Inc. (-6.53), less than Innate Pharma S.A. (-3.10), less than Insight Molecular Diagnostics Inc. (-0.03), less than Codexis, Inc. (-2.50), less than OmniAb, Inc. (-3.55),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.58 | $184.35M | |
| -4.59 | $215.89M | |
| -2.15 | $178.38M | |
| -2.69 | $171.19M | |
| -7.78 | $150.59M | |
| -6.53 | $172.73M | |
| -3.10 | $160.90M | |
| -0.03 | $159.95M | |
| -2.50 | $150.14M | |
| -3.55 | $212.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vyome Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vyome Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vyome Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Vyome Holdings, Inc. (HIND)?
What is the highest PE Ratio for Vyome Holdings, Inc. (HIND)?
What is the 3-year average PE Ratio for Vyome Holdings, Inc. (HIND)?
What is the 5-year average PE Ratio for Vyome Holdings, Inc. (HIND)?
How does the current PE Ratio for Vyome Holdings, Inc. (HIND) compare to its historical average?